American Journal on Addictions

Article	Citations
AAAP's Annual Meeting and Scientific Symposium	26
Issue Information	26
Stand against stigma	23
Self assessment ad (002)	23
Issue Information	21
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada	19
Call for Special Issue 2024	19
2024 Annual Meeting Posters	15
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	15
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	14
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances	13
AAAP 36th Annual Meeting & Scientific Symposium Save the Date	13
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	13
AAAP Stimulant Use Disorder PIP	13
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	12
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	12
Gender differences in circumstances associated with cannabis use	12
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression	11
A scoping review of sensory‐based interventions to address alcohol consumption	11
Become a member of AAAP!	10
Issue Information	10
Narcotics Anonymous members in recovery from methamphetamine use disorder	10
AAAP Annual meeting ad	10
Call for Review Papers 2024	9
Synthetic cannabinoid use and the acquired preparedness model	9

AM Registration Flyer	9
Emotional regulation in Gaming Disorder: A systematic review	9
Call for Special Issue Papers 2025	9
Call for Review Papers 2024	9
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia	9
Correlates of optimism among patients in substance use disorder inpatient treatment	9
Tobacco use and impulsivity in people with mental illness: A systematic review	9
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?	8
Call for Special Issue Papers 2024	8
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population	8
Call for review papers 2021	8
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study	8
Issue Information ‐ Editorial Board	7
Preconference On‐Demand availability	7
	7
Issue Information ‐ Editorial Board	7
Extended‐release buprenorphine in pregnancy	7
Call for review papers 2022	7
Issue Information ‐ ToC	7
AAAP Podcast EP	6
AAAP Call for Abstracts	6
AAAP AATT Preconference	6
Issue Information	6
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications	6
AJA Annual Meeting 2023	6
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates	6
Stand Against Stigma	5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us	5
AAAP's Performance in practice activities	5
Issue Information ‐ ToC	5
2023 Advanced Addiction Psychopharmacology Course	5
Personality predicting relapse: A facet analysis of the NEO PI‐R	5
Issue Information ‐ Editorial Board	5
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study	5
Health care service utilization and drug overdose death: A national nested case–control registry study	5
2021 AJA Reviewer List	4
Call for special issue 2023	4
Cannabis Use Disorders Performance in Practice	4
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)	4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study	4
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder	4
AJA AM Save the Date 2023	4
2023 Addictions and Their Treatment Course	4
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting	4
Addiction specialists' attitudes toward psychedelics: A National Survey	4
Registration open – AAAP annual meeting and pre‐conference courses	4
Call for Special Issue 2023	4
	4
Call for Symposium Abstracts	4
BREAKING NEWS: AAAP Earns a Spot in ACCME's Innovation Partner Circle!	4

Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States	4
	3
AAAP Membership benefits	3
Save the Date ‐ Annual Meeting 2025	3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth	3
Issue Information ‐ Editorial Board	3
AJA AM save the date 2023	3
Medical Update	3
Mini‐Symposia I	3
Stand Against Stigma	3
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort	3
AAAP 2024 Self‐Assessment Exam Now Available	3
FREE WEBINAR: Master MI Techniques with Dr. Brian Borsari, September 10, 2025	2
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain	2
Become an AAAP Member	2
AAAP on‐demand educational activities	2
Concurrent Paper Sessions	2
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem	2
2025 Call for Symposium Abstracts	2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	2
Trends in substance use disorder diagnoses among Veterans, 2009–2019	2
Gambling, tobacco use, and health among individuals in substance use disorder treatment	2
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series	2
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	2
Call for Review Papers 2023	2
Cannabis Use PIP Ad	2
Call for special issue 2023	2
Medication Management for Stimulant Use Disorder Webinar	2
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users	2
Psychotherapy Webinar Series AJA	2
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem	2
Issue Information ‐ Editorial Board	2
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	2
Addiction Psychiatry Advanced Psychotherapy Curriculum	2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study	2
Paper sessions	2
Addiction Psychiatry Advanced Psychotherapy Curriculum	1
AJA Psychedelics	1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center	1
2024 Annual Meeting Posters	1
ORN Advancing racial equity	1
Opioid use disorder in the active service: Implications for intervention	1
Mini‐Symposia II	1
32nd AAAP Annual meeting & scientific symposium recap	1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization	1
Issue Information	1
Issue Information ‐ ToC	1
Educating the community about the opioid epidemic and medications for opioid use disorder	1
Call for special issue 2023	1
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students	1
AAAP Membership	1
Symposium III	1
Film & Media Workshop	1
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review	1
Symposium I	1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	1
AJA Annual Meeting 2024	1
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex	1
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder	1
2023 Advanced Addiction Psychopharmacology Course	1
PCSS exchange AJA Ad	1
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 2024	1
Conference Schedule	1
AAAP ORN PIP ad	1
Legalization of cannabis in Canada—Local media analysis	1
Call for special issue 2023	1
Call for review papers 2022	1
Daily cannabis use may cause cannabis‐induced hyperalgesia	1
Cannabis and the overdose crisis among US adolescents	1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?	1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting	1
Examining family member characteristics by treatment status of the relative with substance use problems	1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder	1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use	1
Motivational Interviewing PIP	0
2023 Reviewer List (n = 223)	0
Reasons for electronic cigarette use: Differences based on sex and young adult status	0

AAAP podcast	0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder	0
Become A AAAP Member!	0
Estimating the effects of prenatal cannabis exposure on birth outcomes	0
Issue Information ‐ Editorial Board	0
Become a AAAP Member	0
AAAP PIPS 2023	0
Call for Review Papers 2024	0
AJA psychedelic Ad	0
Become a AAAP Member	0
Binge drinking and sexual risk behavior among US sexual and gender minority college students	0
Call for Special Issue 2024	0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study	0
Issue Information	0
Symposium IV	0
	0
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use	0
Managing Opioid Use Disorder Care in the Era of Fentanyl	0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)	0
Greater vulnerability to cannabis dependence among heavy cannabis user French women	0
Call for Special Issue 2022	0
Call for Review Papers 2025	0
Response to commentary, from Bisol et al., on “Tobacco use and impulsivity in people with mental illness: A systematic review,” Praecht, A. et al. (2025). Am. J. Addict. 34–4: 383–403	0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial	0
AAAP_Call for Review papers‐2024	0
Call for review papers 2023	0
Medical marijuana access and prolonged opioid use among adolescents and young adults	0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment	0
Symposium II	0
Response to Costa et al.: Caution is warranted when comparing estimates from differently defined study samples	0
Identifying treatment responders to the combination of varenicline and naltrexone	0
Stand against stigma	0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019	0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood	0
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan	0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?	0
Film & Media Workshop	0
Issue Information	0
AAAP Travel Awards Open	0
Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study	0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 2024	0
Issue Information ‐ Editorial Board	0
	0
Call for review papers 2023	0
Trajectories of prescription opioid and heroin use in adulthood	0
Self‐Assessment Exam 2023	0
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program	0
Addictions and their treatment	0
Issue Information	0
Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California	0
Issue Information	0
Motivational Interviewing Performance in Practice	0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths	0
Psychotherapy Webinar Series AJA	0
AAAP Performance and Practice (PIP) Resources	0
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping review	0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?	0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey	0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance	0
	0
Registration Open Now: Virtual Courses on Addictions and Their Treatment (Sep 12–13, 2025) and Advanced Addiction Psychopharmacology (Sep 20–21, 2025)	0
Issue Information	0
Issue Information ‐ Editorial Board	0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US	0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O	0
Conference Schedule	0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone	0
Travel Award AJA	0
Issue Information	0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder	0
CSAM‐SMCA 2022 Scientific conference and annual meeting	0
AAAP Podcast	0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder	0
Issue Information	0
	0
PCSS is here to help!	0
2022 Self‐Assessment examination	0
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients	0
Call for review papers 2022	0
AAAP's Educational Offerings	0
Call for review papers 2022	0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study	0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder	0
2024 Reviewer List	0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial	0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience	0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?	0
AAAP Psychotherapy Curriculum Series	0
Addictions & Their Treatment Virtual Course, Sep 13‐14, 2024 ‐ 50% Discount Preconference 50% Off 2023 Self Assessment Exam	0
Symposia, Medical Update, and Case Conference	0
Issue Information	0
Medication treatment for alcohol use disorder in special populations	0
	0
FREE Online Self‐Assessment Exam: ORN StUD Performance in Practice (PIP)	0
FREE Training & Mentoring: PCSS and ORN	0